Example: Heart Attack

Search clinical trials for: Lansoprazole

Total 257 results

NCT01990339

Completed

Lansoprazole Tablets Special Drug Use Surveillance Gastroesophageal Reflux Disease With Dyspepsia Symptoms

Conditions: Gastroesophageal Reflux Disease With Dyspepsia Symptoms
NCT02151786

Completed

Lansoprazole Intravenous 30 mg Specified Drug-use Survey [Hemostatic Effect/Rebleeding Rate]

Conditions: Gastric Ulcer, Duodenal Ulcer, Acute Stress Gastritis, and Acute Gastric Mucosal Lesions
NCT02170207

Completed

Takepron Intravenous 30 mg Specified Drug-use Survey [Acute Stress Ulcer and Acute Gastric Mucosal Lesions]

Conditions: Acute Stress Ulcer and Acute Gastric Mucosal Lesions
NCT01270308

Completed

Bioequivalence Study of Lansoprazole DR Capsules 30 mg in Fasting Conditions

Conditions: Healthy
NCT02099682

Completed

Long-term Use of Takepron Capsules on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin

Conditions: Gastric or Duodenal Ulcers
NCT02099708

Completed

Long-term Use of Takepron on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs

Conditions: Gastric or Duodenal Ulcers
NCT01778101

Completed

Lansoprazole in Preterm Infants With Reflux

Conditions: Preterm Infants; Gastrointestinal Reflux
NCT03488173

Completed

Pharmacokinetic Study of Lansoprazole Capsules in Healthy Chinese Volunteer

Conditions: Effect of Drugs; Safety Issues
NCT01040455

Terminated

Lansoprazole for Subgroups of Functional Dyspepsia

Conditions: Functional Dyspepsia
NCT01135368

Completed

Safety and Efficacy of Lansoprazole in Patients With Reflux Disease

Conditions: Gastroesophageal Reflux
NCT00175045

Completed

Intravenous vs Oral Lansoprazole on Gastric Acid Secretion in Subjects With Erosive Esophagitis

Conditions: Esophagitis; Reflux
NCT03488186

Completed

PK-PD Comparative Study of Lansoprazole Capsules and Lansoprazole Enteric-coated Capsules in Healthy Chinese Volunteers

Conditions: Effect of Drugs; Safety Issues
NCT00239551

Completed

Effect of Prevacid on Prostaglandin Levels in Patient With Stress Ulcer

Conditions: Stomach Ulcer
NCT01045967

Completed

Lansoprazole 30 mg DR Capsule Fasting Study

Conditions: Healthy
NCT01046084

Completed

Lansoprazole 30 mg DR Capsule Replicate Food Study

Conditions: Healthy
NCT01046253

Completed

Lansoprazole 30 mg DR Capsule Fasting Replicate Sprinkle Study

Conditions: Healthy
NCT03355170

Unknown status

Cardiac Safety of Lansoprazole and Domperidon Combination

Conditions: GERD; Cardiac Event; Safety Issues
NCT00701259

Completed

Efficacy/Safety of Lansoprazole in Patients With Frequent Nighttime Heartburn

Conditions: Frequent Heartburn
NCT03087162

Completed

Once Daily Dose Dexlansoprazole Quadruple Therapy for Helicobacter Pylori

Conditions: H Pylori Eradication
NCT02162758

Terminated

Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barrett's Esophagus With Radiofrequency Ablation

Conditions: Barrett's Esophagus
NCT03316976

Completed

A Study to Evaluate the Pharmacokinetics of Dexlansoprazole 30 Milligram (mg) and 60 mg Delayed-release Capsules in Healthy Chinese Participants

Conditions: Healthy Volunteers
NCT01155284

Completed

Combination Therapy With Sitagliptin and Lansoprazole to Restore Pancreatic Beta Cell Function in Recent-Onset Type 1 Diabetes

Conditions: Type 1 Diabetes
NCT01642602

Completed

Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules in Treating Symptomatic Non-Erosive Gastroesophageal Reflux Disease in Adolescents

Conditions: Gastroesophageal Reflux Disease
NCT00220818

Completed

A Study to Evaluate the Effect of Lansoprazole on Infants With Gastroesophageal Reflux Disease.

Conditions: Gastroesophageal Reflux Disease
NCT01637571

Withdrawn

Dexilant Treatment in Gastrointestinal Reflux Disease (GERD Related Non Cardiac Chest Pain

Conditions: Chest Pain; Gastrointestinal Reflux Disease